DEFRA, BBSRC, NERC and the Food Standards Agency are co-hosting a UK Info Day the 2013 FP7 Food, Agriculture and Fisheries, and Biotechnologies (FAFB) and Environment (including climate change) calls on Friday 6 July. The venue is the Royal Pharmaceutical Society in London. Registration for the event is now open, simply complete and return this Registration Form. There is no charge for this event, and places are limited and will be on a first-come first-served basis.The information day is designed for everyone interested in these two FP7 thematic areas, in particular those considering submitting a proposal for the 2013 work programme calls. These are scheduled to be published on around 10 July, and will be the last such calls under FP7. The information day will feature:
- Presentations from the European Commission’s DG Research and Innovation on the 2013 work programmes for the FAFB and Environment themes;
- Information on the opportunities available in other FP7 schemes, including the “Ideas” (the European Research Council) and “People” (the Marie Curie Actions) programmes;
- Presentations by FP7 project participants in the FAFB and Environment areas, along with lessons learned about participating in the programme; and
- An update on Horizon 2020.
The UK National Contact Point for the FAFB and Environment themes will be available all day to provide information and advice on participation in FP7. The event will also provide an opportunity to network with others interested in EU collaborative research.











BU PhD student attending HIV conference on scholarship
ESRC SWDTP – Applications open for PhD Studentships for September 2026
New paper by CMWH PhD student
Further CMWH contributions to 2026 ICM congress
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease